Content about Otelixizumab

March 11, 2011
GSK, Tolerx's late-stage trial for otelixizumab doesn't meet endpoints

A late-stage trial of a biologic treatment for Type 1 diabetes appears to have failed, according to results announced Friday.

July 18, 2010
As diabetes rates grow, R&D pipelines flow

Research and development pipelines are flowing with a record number of drugs for treating diabetes...

© 2013 Drug Store News. All Rights Reserved.